Literature DB >> 10839552

Treatment of prostatitis.

J J Stevermer1, S K Easley.   

Abstract

The term prostatitis is applied to a series of disorders, ranging from acute bacterial infection to chronic pain syndromes, in which the prostate gland is inflamed. Patients present with a variety of symptoms, including urinary obstruction, fever, myalgias, decreased libido or impotence, painful ejaculation and low-back and perineal pain. Physical examination often fails to clarify the cause of the pain. Cultures and microscopic examination of urine and prostatic secretions before and after prostatic massage may help differentiate prostatitis caused by infection from prostatitis with other causes. Because the rate of occult infection is high, a therapeutic trial of antibiotics is often in order even when patients do not appear to have bacterial prostatitis. If the patient responds to therapy, antibiotics are continued for at least three to four weeks, although some men require treatment for several months. A patient who does not respond might be evaluated for chronic nonbacterial prostatitis, in which nonsteroidal anti-inflammatory drugs, alpha-blocking agents, anticholinergic agents or other therapies may provide symptomatic relief.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10839552

Source DB:  PubMed          Journal:  Am Fam Physician        ISSN: 0002-838X            Impact factor:   3.292


  8 in total

1.  Overview of overactive bladder, prostatitis, and lower urinary tract symptoms for the primary care physician.

Authors:  Richard S Pelman
Journal:  Rev Urol       Date:  2004

Review 2.  Tamsulosin: a review of its pharmacology and therapeutic efficacy in the management of lower urinary tract symptoms.

Authors:  Christopher J Dunn; Anna Matheson; Diana M Faulds
Journal:  Drugs Aging       Date:  2002       Impact factor: 3.923

3.  Effects of repeated oral administration of pazufloxacin mesylate and meloxicam on the antioxidant status in rabbits.

Authors:  Adil Mehraj Khan; Satyavan Rampal
Journal:  J Am Assoc Lab Anim Sci       Date:  2014-07       Impact factor: 1.232

4.  Positive Response to Thermobalancing Therapy Enabled by Therapeutic Device in Men with Non-Malignant Prostate Diseases: BPH and Chronic Prostatitis.

Authors:  Ivan Gerasimovich Aghajanyan; Simon Allen
Journal:  Diseases       Date:  2016-04-18

5.  Escherichia coli associated hematogenous sternoclavicular joint osteomyelitis: A rare condition with a rare causative pathogen.

Authors:  Tyler Luu; Gail Reid; Brian Lavery
Journal:  IDCases       Date:  2022-01-06

6.  Azithromycin and Ceftriaxone Differentially Activate NLRP3 in LPS Primed Cancer Cells.

Authors:  Gulcin Tezcan; Mohammad Alsaadi; Shaimaa Hamza; Ekaterina E Garanina; Ekaterina V Martynova; Gulshat R Ziganshina; Elina R Farukshina; Albert A Rizvanov; Svetlana F Khaiboullina
Journal:  Int J Mol Sci       Date:  2022-08-22       Impact factor: 6.208

Review 7.  Inflammatory mechanisms and oxidative stress in prostatitis: the possible role of antioxidant therapy.

Authors:  Gianni Paulis
Journal:  Res Rep Urol       Date:  2018-09-17

8.  Doxycycline Attenuates Cancer Cell Growth by Suppressing NLRP3-Mediated Inflammation.

Authors:  Mohammad Alsaadi; Gulcin Tezcan; Ekaterina E Garanina; Shaimaa Hamza; Alan McIntyre; Albert A Rizvanov; Svetlana F Khaiboullina
Journal:  Pharmaceuticals (Basel)       Date:  2021-08-26
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.